Vivo Capital, LLC Dbv Technologies S.A. Put Options Transaction History
Vivo Capital, LLC
- $748 Million
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding DBVT
# of Institutions
35Shares Held
37.7MCall Options Held
0Put Options Held
0-
Baker Bros. Advisors LP New York, NY14.6MShares$12.3 Million0.14% of portfolio
-
Braidwell LP Stamford, CT7.84MShares$6.59 Million0.19% of portfolio
-
Yiheng Capital Management, L.P. San Francisco, CA5.57MShares$4.68 Million0.23% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.11MShares$2.61 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.11MShares$932,1630.0% of portfolio
About DBV Technologies S.A.
- Ticker DBVT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,776,992
- Market Cap $158M
- Description
- DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...